SEHK:1548Life Sciences
Is It Time To Reassess Genscript Biotech (SEHK:1548) After Its Recent Share Price Recovery?
If you are wondering whether Genscript Biotech at HK$13.85 is priced for opportunity or already reflecting the story, this valuation breakdown is designed to give you a clear starting point.
The stock has returned 0.7% over the last 7 days, 25.8% over the last 30 days, 8.3% year to date, and 25.2% over 1 year, while the 3 year and 5 year returns sit at 32.8% and 23.1% declines respectively.
These mixed returns mean context really matters. Recent company updates, financing decisions,...